{"transactions":[{"id":4629996,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-05T20:14:39.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":126,"price":3.94,"value":496.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":14015,"source":{"system":"sec-edgar","filing":"0001193125-26-414135","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526414135/ownership.xml","form_type":"4"}},{"id":4616964,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T20:24:02.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":43700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 21, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":43700,"derivative":{"exercise_price":5.52,"expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":43700},"source":{"system":"sec-edgar","filing":"0001193125-26-390624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526390624/ownership.xml","form_type":"4"}},{"id":4616963,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-14T20:24:02.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":203,"price":5.52,"value":1120.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":14141,"source":{"system":"sec-edgar","filing":"0001193125-26-390624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526390624/ownership.xml","form_type":"4"}},{"id":4616962,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-14T20:24:02.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":9038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a period of four years from April 21, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. The RSUs will be settled in shares of Common Stock upon vesting."}],"balance_after":14344,"source":{"system":"sec-edgar","filing":"0001193125-26-390624","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526390624/ownership.xml","form_type":"4"}},{"id":715546,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-07-06T22:00:07.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":125,"price":7.8,"value":975.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":5306,"source":{"system":"sec-edgar","filing":"0001193125-26-296504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526296504/ownership.xml","form_type":"4"}},{"id":3032447,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Common Stock","published_at":"2020-09-15T00:42:06.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest on December 31, 2021, subject to the Reporting Person's continuous service through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001595585-20-000125","document":"wf-form4_160013051063469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816654/000159558520000125/wf-form4_160013051063469.xml","form_type":"4"}},{"id":3095424,"issuer":{"id":122050,"kind":"organization","name":"Tricida, Inc.","symbol":"TCDA"},"owners":[{"id":32184,"kind":"person","name":"Cobo Marc","position":1,"cik":"0001816654","reported_name":"Cobo Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & CAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-02T00:14:55.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest 25% on June 29, 2021, and the remaining 75% will vest in 36 substantially equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.  The option contained an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase."}],"balance_after":80000,"derivative":{"exercise_price":25.55,"expiration_date":"2030-06-28","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001595585-20-000102","document":"wf-form4_159364887143225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816654/000159558520000102/wf-form4_159364887143225.xml","form_type":"4"}}]}